Biopharma Leaders Look to Leverage Lessons Learned from the Pandemic

Several biotech executives provided their thoughts on lessons learned from the pandemic and what they hope or expect to see moving forward in the industry.

Although the COVID-19 pandemic is still raging in parts of the world, such as India, it is fading in the U.S. and much of Europe. The biopharma industry has been at the forefront of the battle against the disease, and much of the success in fighting it has been the result of the fast development of vaccines and therapeutics.